MannKind Corporation (MNKD) Names Duane DeSisto as President and CEO 12/29/2015
MannKind Corporation Names Duane DeSisto as President and CEO
MannKind Corporation (MNKD) Names Duane DeSisto as President and CEO
Announces Appointment of Duane DeSisto
as Chief Executive Officer
VALENCIA, Calif., Dec. 23, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) and (TASE:MNKD) today announced the appointment of Duane M. DeSisto as its President and Chief Executive Officer, effective January 5, 2016, replacing Alfred Mann who has served as interim CEO since November 19, 2015.
Mr. DeSisto was also appointed to fill an existing vacancy on the board of directors, effective January 5, 2016.
Previously, Mr. DeSisto served as the Chief Executive Officer and President of Insulet Corporation, a medical device company, from 2003 to 2014.
From 2002 to 2003, he served as the President, Chief Financial Officer and Acting Chief Executive Officer of Insulet Corporation and, from 2001 to 2002, he served as the Chief Financial Officer and Treasurer of Insulet Corporation.
"Duane is a respected industry veteran with a strong track record of developing and commercializing disruptive technology for the management of diabetes," said Alfred Mann, Executive Chairman of MannKind.
experience will be instrumental as we seek to enhance the commercial opportunity for AfrezzaÂ® and pursue additional product opportunities within our pipeline.
We are excited to welcome Duane
to the team and look forward to his
"I am thrilled to be joining MannKind
and I look forward to working with the Board and leadership team to help Afrezza realize its full potential," said Mr. DeSisto
has world-class pharmaceutical technology that has the potential to address a large number of unmet medical needs, and I am excited by the opportunities at MannKind
for creating significant value for our shareholders."
From 1999 to 2001, Mr. DeSisto served in various positions at PaperExchange.com, Inc., a business solutions provider for the pulp and paper industry, including as President, Chief Executive Officer and Chief Financial officer.
From 1995 to 1999, Mr. DeSisto served as the Chief Financial Officer of FGX International Holdings Limited (formerly AAI-Foster Grant, Inc.), an accessories wholesaler, where he had overall responsibility for the accounting, information technology and human resource departments.
From 1986 to 1995, Mr. DeSisto served as the chief financial officer of ZOLL Medical Corporation, a medical device company specializing in noninvasive resuscitation devices and related software solutions.
Mr. DeSisto earned a Bachelor of Science from Providence College and a Master of Business Administration from Bryant College.
This press release contains forward-looking statements that involve risks and uncertainties, including statements regarding Mr. DeSisto's
expected contributions to MannKind
, the potential of Afrezza and MannKind's
technology platform and MannKind's
future development plans.